Cancer type | Implications | References |
---|---|---|
Lung cancer | Poor prognosis | |
Hepatocellular carcinoma | Promotes metastasis and predicts poor prognosis | |
Epithelial ovarian cancer | Poor prognosis | [107] |
Breast cancer | Elevated epithelial-mesenchymal transition | |
Leiomyosarcoma | Prognostic factor | [110] |
Esophageal squamous cell carcinoma | Poor prognosis | [111] |
Gallbladder adenocarcinoma | Progression, metastasis, and poor-prognosis | [98] |
Colorectal cancer | Poor prognosis | [112] |
Gastric cancer | Poor prognosis | [113] |
Clear cell renal cell carcinoma | Elevated reoccurrence | [114] |
Melanoma | Elevated metastasis and poor prognosis | [115] |
Hematological malignancies | Elevated tumorigenesis | [116] |
Peripheral nerve tumors | Modulator of malignant transformation | [117] |
Parotid carcinoma | Elevated progression and invasion | [118] |
Non-small cell lung cancer | Poor prognosis | [12] |
Infantile haemangioma | Elevated progression | [119] |
Adenoid cystic carcinoma | Elevated progression | [120] |
Malignant pleural mesothelioma | Poor prognosis | [121] |
Pancreatic cancer | Poor Prognosis and cancer progression | [14] |
Cervical cancer | Dissemination and metastasis | [123] |
Endometrium | Dissemination and metastasis | [123] |
Prostate cancer | Poor prognosis | [122] |